.Merck trumps profits desires, brings up sales expectation on sturdy requirement for best drugs like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Projections as Keytruda Purchases Surge BloombergMerck Supply: Pharma Giant Posts Tough Results, However Outlook Drops Short Capitalist's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck trumps revenue and also sales desires among Keytruda strong point, yet gives blended full-year outlook MarketWatch.